These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9408915)

  • 1. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.
    Smith GS; Schloesser R; Brodie JD; Dewey SL; Logan J; Vitkun SA; Simkowitz P; Hurley A; Cooper T; Volkow ND; Cancro R
    Neuropsychopharmacology; 1998 Jan; 18(1):18-25. PubMed ID: 9408915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
    Aalto S; Hirvonen J; Kajander J; Scheinin H; Någren K; Vilkman H; Gustafsson L; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 2002 Dec; 164(4):401-6. PubMed ID: 12457270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects.
    Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND
    Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
    Vollenweider FX; Vontobel P; Oye I; Hell D; Leenders KL
    J Psychiatr Res; 2000; 34(1):35-43. PubMed ID: 10696831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
    Aalto S; Ihalainen J; Hirvonen J; Kajander J; Scheinin H; Tanila H; Någren K; Vilkman H; Gustafsson LL; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 2005 Nov; 182(3):375-83. PubMed ID: 16001106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.
    Breier A; Adler CM; Weisenfeld N; Su TP; Elman I; Picken L; Malhotra AK; Pickar D
    Synapse; 1998 Jun; 29(2):142-7. PubMed ID: 9593104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
    Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.
    Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP
    Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
    Smith GS; Ma Y; Dhawan V; Chaly T; Eidelberg D
    Synapse; 2009 Jan; 63(1):1-6. PubMed ID: 18925655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
    Farde L; Hall H; Pauli S; Halldin C
    Synapse; 1995 Jul; 20(3):200-8. PubMed ID: 7570351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
    Olsson H; Halldin C; Swahn CG; Farde L
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution volume ratios without blood sampling from graphical analysis of PET data.
    Logan J; Fowler JS; Volkow ND; Wang GJ; Ding YS; Alexoff DL
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):834-40. PubMed ID: 8784228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
    Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR
    J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of striatal dopamine release elicited with NMDA antagonists: is there anything there to be seen?
    Rabiner EA
    J Psychopharmacol; 2007 May; 21(3):253-8. PubMed ID: 17591653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
    Kobayashi K; Inoue O; Watanabe Y; Onoe H; Långström B
    J Neural Transm Gen Sect; 1995; 100(2):147-51. PubMed ID: 8962684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.